Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02233335 |
Date of registration:
|
27/08/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
The Factors Associated With the Recurrence in Patients With Cushing Disease
|
Scientific title:
|
The Factors Associated With the Recurrence in Patients With Cushing Disease |
Date of first enrolment:
|
June 2013 |
Target sample size:
|
42 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02233335 |
Study type:
|
Observational |
Study design:
|
Observational Model: Case Control, Time Perspective: Retrospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Taiwan
| | | | | | | |
Contacts
|
Name:
|
Tien-Chun Chang, M.D., Ph.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Department of Internal Medicine, National Taiwan University Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosed Cushing's disease
Exclusion Criteria:
- Already received treatment in other hospital
- Ectopic Cushing's syndrome
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Cushing Disease
|
Primary Outcome(s)
|
Number of participants with disease persistence or recurrence after surgery, which was determined by clinical symptoms, biochemical lab, dynamic test and image study
[Time Frame: participants were followed at 3 months after treatment for short-term outcome measure and followed until the last hospital visit, an average of 4.7 years, for long-term outcome measure]
|
Secondary ID(s)
|
201305026RINC
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|